Caspofungin versus liposomal amphotericin B for empirical therapy [1] (multiple letters)

Dimitrios P. Kontoyiannis, Russell E. Lewis, Pierre Tattevin, Benoît Bareau, Christophe Camus, Francisco M. Marty, Colleen M. Lowry, Markus Schneemann, Alexander Imhof, Patrick J. Danaher, Brian L. Jones, Lorna A. McLintock, Thomas J. Walsh, Gerald R. Donowitz, Ben E. DePauw